Nordhealth AS (OSL:NORDH)
Norway · Delayed Price · Currency is NOK 36.80
-0.20 (-0.54%)
Jan 30, 2026, 9:58 AM CET
Nordhealth AS Revenue
Nordhealth AS had revenue of 12.93M EUR in the quarter ending September 30, 2025, with 15.23% growth. This brings the company's revenue in the last twelve months to 50.37M, up 15.30% year-over-year. In the year 2024, Nordhealth AS had annual revenue of 45.68M with 24.03% growth.
Revenue (ttm)
50.37M EUR
Revenue Growth
+15.30%
P/S Ratio
5.00
Revenue / Employee
111.94K EUR
Employees
450
Market Cap
2.95B NOK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.68M | 8.85M | 24.03% |
| Dec 31, 2023 | 36.83M | 5.78M | 18.60% |
| Dec 31, 2022 | 31.05M | 10.75M | 52.96% |
| Dec 31, 2021 | 20.30M | 7.62M | 60.04% |
| Dec 31, 2020 | 12.68M | 5.04M | 66.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Navamedic ASA | 539.42M |
| Photocure ASA | 537.59M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| ArcticZymes Technologies ASA | 109.99M |
| Nykode Therapeutics AS | 73.37M |
Nordhealth AS News
- 2 months ago - Nordhealth AS (FRA:6E5) Q3 2025 Earnings Call Highlights: Revenue Growth and AI Investments ... - GuruFocus
- 2 months ago - Q3 2025 Nordhealth AS Earnings Call Transcript - GuruFocus